Profound Medical Corp. Announces Pricing of up to $40 Million Financing Comprised of a $36 Million Registered Direct Offering and a Subsequent $4 Million Private Placement
Financing included participation by healthcare-dedicated investors alongside existing shareholders TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) — Profound Medical Corp. (Nasdaq:PROF; TSX:PRN) ("Profound" or the "Company") today announced the sale of 5,142,857 comm
(Financial Post, 2025-12-19T13:48:37Z)